The organic guidance of 15% for FY 20/21 which roughly matches consensus from marketscreener.com, (which has next 3 years cons ebitda at 152 (FY19), 179(18%), 203m (13%)). However there are expected to be acquisitions in this period, but the outlook suggests hitting this without any, to likely move it quite a way ahead of consensus. The other thing is that this organic growth seems quite conservative compared to the past performance.
Will be interesting to see what the market thinks of CTD's results later this year, if there is no acquisition to cloud things in this period. I personally doubt there will be a problem in the accounts. I'm not even sure why they are worrying about it tbh. I guess if it doesn't cost CTD a great acq opp - then why not?
The organic guidance of 15% for FY 20/21 which roughly matches...
Add CTD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.06 |
Change
-0.230(1.61%) |
Mkt cap ! $1.780B | |||
| Open | High | Low | Value | Volume |
| $14.36 | $14.36 | $13.92 | $7.090M | 503.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1773 | $14.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 1428 | 4 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| CTD (ASX) Chart |
